Tag: AEON Biopharma Inc.

Migraine treatment

United States

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Doses First Patient in Phase 2 Trial of ABP-450 for the Treatment of Cervical ...

Added to Collection on: 2021-04-05 12:00:00

Tags for this article:

Clinical trial

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Appoints Dr. Chad K. Oh as Chief Medical Officer to Lead Clinical Development ...

Added to Collection on: 2021-06-09 12:01:11

Tags for this article:

Pharmaceutical industry

Botulinum toxin

Neurotoxins

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Reports Positive Topline Results from Phase - GlobeNewswire

Added to Collection on: 2022-09-23 11:01:50

Tags for this article:

Priveterra Acquisition Corp.

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Investors Contribute Additional $20 Million to SPAC Deal

Added to Collection on: 2023-01-10 23:37:03

Tags for this article:

Initial public offering

Prevention of migraine attacks

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Announces Topline Results from Phase 2 Trial - GlobeNewswire

Added to Collection on: 2023-10-19 20:08:59

Tags for this article:

Migraine

Botulinum toxin

Placebo-controlled study

Occipital nerve stimulation

United States

Canada

Click the tags to see associated articles and topics

View Article Details

AEON Biopharma Presents Positive Clinical and Pre-clinical - GlobeNewswire

Added to Collection on: 2024-01-18 21:16:53

Tags for this article:

Stellate ganglion

Posttraumatic stress disorder

SGB

Lidocaine

Tetanospasmin